000 04366cam a22003974i 4500
999 _c5503
_d5503
001 15762208
005 20201021112709.0
008 090603s2011 maua b 001 0 eng
010 _a 2009022814
020 _a9780763761615
020 _a0763761613
040 _aDNLM/DLC
_cDLC
_dYDX
_dNLM
_dDLC
_erda
050 0 0 _aRC683.5.C5
_bC37 2011
082 0 0 _a616.12075
_222
_bC
245 0 0 _aCardiac biomarkers in clinical practice /
_cedited by James L. Januzzi, Jr.
264 1 _aSudbury, Mass. :
_bJones and Bartlett Publishers,
_c[2011]
264 4 _c©2011
300 _axx, 892 pages :
_billustrations (some color) ;
_c21 cm
336 _2rdacontent
_atext
337 _2rdamedia
_aunmediated
338 _2rdacarrier
_avolume
504 _aIncludes bibliographical references and index.
505 0 _aSection One: Necrosis Markers -- Chapter 1: Biology of Standard Necrosis Markers -- Chapter 2: The Evolution and Revolution of Necrosis Markers in Modern Cardiology for the Diagnosis of Acute Myocardial Infarction -- Chapter 3: Biochemical and Analytical Issues for Cardiac Troponin -- Chapter 4: Utility of Troponin Testing for Risk Stratification and Treatment Decision Making in Acute Coronary Syndromes -- Chapter 5: Use of Cardiac Troponins in ST-Segment Elevation Myocardial Infarction -- Chapter 6: Interpretation of Cardiac Troponin Elevation in Patients with End-stage Renal Disease -- Chapter 7: Necrosis Market Testing in Heart Failure -- Chapter 8: Necrosis Markers in Conditions Other than Acute Coronary Syndromes and Heart Failure -- Chapter 9: Use of Cardiac Necrosis Biomarkers Following PCI or CABG -- Chapter 10: Emerging Biomarkers in Acute Coronoary Syndrome -- Chapter 11: Ischemia Markers -- Section Two: Inflammatory Markers -- Chapter 12: Inflammation and Inflammatory Markers in Cardiovascular Disease: From Bench to Bedside -- Chapter 13: Inflammation in The Development and Complications of Coronary Artery Disease -- Chapter 14: Role of Inflammatory Marker Testing in Acute Coronary Syndromes -- Chapter 15: Role of Inflammatory Biomarkers in heart Failure -- Section Three: Natriuretic Peptides -- Chapter 16: Biology of the Natriuretic Peptides -- Chapter 17: Natriuretic Peptide Testing: Laboratory Considerations -- Chapter 18: Natriuretic Peptides and Structural Heart Disease -- Chapter 19: Population Testing with Natriuretic Peptides -- Chapter 20: Natriuretic Peptide Testing in Symptomatic Primary Care Patients -- Chapter 21: Natriuretic Peptide Testing for Diagnostic Evaluation of Patients with suspected Acute Hearth Failure -- Chapter 22: Natriuretic Peptide Testing for Patients with Acute and Chronic Coronary Disease -- Chapter 23: Natriuretic Peptides and Prognostication: Predicting Outcomes Across the Spectrum of Medical Conditinos -- Chapter 24: Natriuretic peptides for Guidance of Acute and Chronic Heart Failure therapy -- Chapter 25: Natriuretic Peptide Testing in Patients with Renal Disease -- Chapter 26: Emerging Biomarkers of Cardiac Failure -- Section Four: Markers of Thrombosis and Hemostasis -- Chapter 27: Rationale for Clinical Measurement of Markers in Cardiology -- Chapter 28: Markers of Platelet Function and Assessment of Platelet Activation and Aggregation -- Section Five: Lipid Markers -- Chapter 29: Contemporary Interpretation of Lipid Guidelines in Modern Medicine -- Chapter 30: Biomarkers in the Metabolic Syndrome -- Chapter 31: Emerging Lipid-Based Biomarkers -- Section Six: The "-omics": Genomic, Metabolomic, and Protecomic Markers -- Chapter 32: Genetic Biomarkers
520 _aCardiac Biomarkers in Clinical Practice presents a case based approach to biomarkers in heart diseases including heart failure, ischemic heart disease, and outpatient. Divided into six sections, this book provides physicians and other health care providers with a clear understanding of the role of biomarkers in clinical cardiovascular medicine
650 0 _aHeart
_xDiseases
_xDiagnosis.
650 0 _aBiochemical markers
_xDiagnostic use.
650 0 _aClinical chemistry.
650 1 2 _aBiological Markers.
650 1 2 _aCardiovascular Diseases
_xdiagnosis.
650 2 2 _aCardiovascular Diseases
_xprevention & control.
650 2 2 _aRisk Assessment.
700 _aJanuzzi, James L.
_933539
_eauthor.
942 _cBK
_2ddc